(ACTUALITÉ EN BREF) Une nouvelle société dérivée de découverte de médicaments de l’Université de Liverpool appelée Sulantrix explore de nouveaux médicaments contre le cancer ciblant des classes de pseudoenzymes jusqu’alors inexploitées. La société est dirigée par le professeur Patrick Eyers … Read the full press release →
Posted in Education, Healthcare, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Cancer, David Williams, découverte de médicaments, Dr Emma Fairweather, Emma Nolan, essaimage, financement des investissements d'entreprise, IA, ISMIB, plateformes multi-omiques, professeur Anthony Hollander, professeur Patrick Eyers, pseudoenzymes, Sulantrix, Université de Liverpool
(COMMUNIQUÉ DE PRESSE) BRISTOL, 19-Apr-2022 — /EuropaWire/ — University of Bristol, a red brick research university, has announced that it is joining UK’s new National Mouse Genetics Network, a distributed challenge-led research clusters working with the Mary Lyon Centre to … Read the full press release →
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?
Load more...
| L | M | M | J | V | S | D |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | 31 | |||||